The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica Is BPC 157 Banned? Oral vs. Injectable Forms Explained FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York